Vectus Biosystems Ltd (VBS.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251 | 809 | 2,951 | 1,281 | 5,778 |
| Receivables | N/A | 976 | 1,434 | 2,318 | N/A |
| Inventories | 1 | 1 | 1 | 0 | N/A |
| Other current assets | 438 | 0 | 0 | 0 | 41 |
| TOTAL | $778 | $1,843 | $4,457 | $3,729 | $5,969 |
| Non-Current Assets | |||||
| PPE Net | 4 | 182 | 173 | 208 | 73 |
| TOTAL | $4 | $182 | $173 | $208 | $73 |
| Total Assets | $783 | $2,026 | $4,630 | $3,936 | $6,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 5,890 | 442 |
| Accounts payable and accrued liabilities | 534 | 187 | 220 | 120 | 328 |
| Other current liabilities | 287 | 128 | 360 | 888 | 439 |
| TOTAL | $836 | $535 | $1,076 | $7,398 | $1,655 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200 | N/A | N/A | N/A | 7,191 |
| Other Non-Current Liabilities | 3 | 5 | 3 | 2 | 2 |
| TOTAL | $203 | $5 | $30 | $72 | $7,210 |
| Total Liabilities | $1,039 | $539 | $1,106 | $7,470 | $8,865 |
| Shareholders' Equity | |||||
| Common Shares | 38,369 | 38,369 | 38,352 | 27,303 | 24,835 |
| Retained earnings | -39,503 | -37,726 | -35,632 | -32,183 | -29,125 |
| Other shareholders' equity | 878 | 844 | 803 | 1,346 | 1,468 |
| TOTAL | $-257 | $1,486 | $3,524 | $-3,534 | $-2,823 |
| Total Liabilities And Equity | $783 | $2,026 | $4,630 | $3,936 | $6,043 |